378 FAECAL MICROBIOTA TRANSPLANTATION FOR POST-ACUTE COVID-19 SYNDROME: AN OPEN-LABEL PILOT TRIAL (FMT-PACS STUDY)
Leggi →
Maggio 2024
Risultati per: Cardio-oncology: rivista open access
Questo è quello che abbiamo trovato per te
Sa1089 ACCESS TO PARACENTESIS DRIVES AVOIDABLE HEALTHCARE UTILIZATION IN EMERGENCY DEPARTMENT PATIENTS WITH CIRRHOSIS.
Leggi →
Maggio 2024
Sa1012 COST AND NON COST RELATED BARRIERS TO HEALTHCARE ACCESS AMONG SEXUAL AND GENDER MINORITY INDIVIDUALS WITH IBD ENROLLED IN THE NATIONAL INSTITUTES OF HEALTH ALL OF US RESEARCH PROGRAM
Leggi →
Maggio 2024
Sa1037 ASSESSING GAPS IN ACCESS TO HEPATOBILIARY PROCEDURES IN CHOLEDOCHOLITHIASIS AND CHOLANGITIS
Leggi →
Maggio 2024
652 WHO SUFFERS FROM OCCASIONAL CONSTIPATION? CLINICALPSYCHOLOGICAL CHARACTERISTICS AND ASSOCIATED FACTORS IN AN OPEN POPULATION IN MEXICO.
Leggi →
Maggio 2024
971 LOW-MOLECULAR-WEIGHT HEPARIN PLUS INSULIN VERSUS INSULIN ALONE FOR HYPERTRIGLYCERIDEMIA-ASSOCIATED ACUTE PANCREATITIS: A MULTICENTER, OPEN-LABEL, RANDOMIZED, CONTROLLED TRIAL
Leggi →
Maggio 2024
Sa1767 A COST-EFFECTIVE INFLAMMATORY BOWEL DISEASE FLARE MANAGEMENT PATHWAY UTILISING RAPID ACCESS INTESTINAL ULTRASOUND AND NURSE-LED TRIAGE TO ACHIEVE HOSPITAL AVOIDANCE WITH HIGH PATIENT SATISFACTION
Leggi →
Maggio 2024
Sa1364 TEN-VERSUS FOURTEEN-DAY VONOPRAZAN AND HIGH-DOSE AMOXICILLIN DUAL-THERAPY FOR HELICOBACTER PYLORI ERADICATION: A PROSPECTIVE, OPEN-LABELED, MULTICENTER, RANDOMIZED NONINFERIORITY STUDY
Leggi →
Maggio 2024
545 A QUALITY-OF-CARE INITIATIVE TO IMPROVE URGENT CARE ACCESS IN AMBULATORY CLINICS IS ASSOCIATED WITH REDUCED INPATIENT COSTS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE IBD QORUS URGENT CARE IMPROVEMENT INITIATIVE
Leggi →
Maggio 2024
Sa1515 USE OF OPEN AND LAPAROSCOPIC CHOLECYSTECTOMY AMONG ADULTS WITH ACUTE CHOLECYSTITIS AND PREDICTORS OF CONVERSION OF LAPAROSCOPIC PROCEDURES INTO OPEN
Leggi →
Maggio 2024
989 EFFICACY AND SAFETY OF OBEFAZIMOD IN UC PATIENTS AT WEEKS 48 AND 96 OF AN OPEN-LABEL MAINTENANCE STUDY AMONG CLINICAL RESPONDERS AT WEEK 8 OF THE PHASE 2B INDUCTION TRIAL
Leggi →
Maggio 2024
Mo1400 COMPARATIVE ANALYSIS OF TECHNIQUES FOR CHALLENGING BILIARY ACCESS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Leggi →
Maggio 2024
Mo1585 ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ELAFIBRANOR WITH WARFARIN IN HEALTHY ADULT MALE PARTICIPANTS: AN OPEN-LABEL PHASE I TRIAL
Leggi →
Maggio 2024
Su1694 RECENT TRENDS AND OUTCOMES OF COLOSTOMY REVERSAL IN NONMALIGNANT CONDITIONS: A RETROSPECTIVE COMPARATIVE STUDY OF OPEN, LAPAROSCOPIC, AND ROBOTIC APPROACHES
Leggi →
Maggio 2024
Su1700 IMPACT OF CONVERSION FROM ROBOTIC AND LAPAROSCOPIC TO OPEN COLECTOMIES ON ONCOLOGICAL OUTCOMES
Leggi →
Maggio 2024
Sa1628 SEROCONVERSION RATE AFTER 3-DOSES OF HEPLISAV B IS BETTER THAN 2-DOSES IN PATIENTS WITH LIVER DISEASE: AN OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY
Leggi →
Maggio 2024
